ATP-sensitive potassium channels - Neonatal diabetes mellitus and beyond

New England Journal of Medicine

Volumn 355, Issue 5, 2006, Pages 507-510

  Sperling, Mark A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMINO ACID; GLIBENCLAMIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOKINASE; GLUCOSE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SOMATOMEDIN; SULFONYLUREA; SULFONYLUREA RECEPTOR 1; TOLBUTAMIDE; TRANSCRIPTION FACTOR PDX 1; ZINC FINGER PROTEIN;

CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; GENE MUTATION; GENETIC CODE; GESTATION PERIOD; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN DEFICIENCY; INSULIN RELEASE; INTRAUTERINE GROWTH RETARDATION; METABOLIC REGULATION; NEWBORN DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ZONA INCERTA;

ATP-BINDING CASSETTE TRANSPORTERS; DIABETES MELLITUS; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INFANT, NEWBORN; INSULIN; INSULIN-SECRETING CELLS; MUTATION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; SULFONYLUREA COMPOUNDS;

EID: 33746681908     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068142     Document Type: Editorial

References (12)

1. Sperling MA. Neonatal diabetes mellitus: from understudy to center stage. Curr Opin Pediatr 2005;17:512-8.
2. Ma D, Shield JP, Dean W, et al. Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM. J Clin Invest 2004;114:339-48.
3. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001;345:971-80.
4. Gloyn AL, Pearson ER, Antcliff JF, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838-49. [Erratum, N Engl J Med 2004;351:1470.]
5. Pearson ER, Flechtner I, Njølstad PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467-77.
6. Babenko AP, Polak M, Cave H, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006;355:456-66.
7. Augilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995;268:423-6.
8. Inagaki N, Gonoi T, Clement JP IV, et al. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270:1166-70.
9. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 2005;115:2047-58.
10. Thomas PM, Cote GJ, Wohllk N, et al. Mutation in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-9.
11. Dekelbab B, Sperling MA. Hypoglycemia in newborns and infants. Adv Pediatr (in press).
12. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005;54:2503-13.